Skip to main content
NCBI home page
Gut logoLink to Gut
. 1988 Aug;29(8):1058–1063. doi: 10.1136/gut.29.8.1058

Mucosal biotransformation rates in the small intestine of children.

M R Ståhlberg 1, E Hietanen 1, M Mäki 1
PMCID: PMC1433902  PMID: 3410332

Abstract

Biotransformation of ingested xenobiotics is known to take place in the gastrointestinal mucosa of laboratory animals and adult humans as well as in the liver. We studied the activities of aryl hydrocarbon hydroxylase, epoxide hydrolase, and glutathione peroxidase in 242 peroral small intestinal biopsy samples of children aged eight months to 18 years: 201 with normal histology, 21 with partial villous atrophy, and 20 with severe villous atrophy. All these enzymes were detectable even in the youngest children. The aryl hydrocarbon hydroxylase activity was age dependent, while the other measured enzyme activities were not related to the age of the patients. The aryl hydrocarbon hydroxylase activity was not related to the mucosal histology, but the epoxide hydrolase and glutathione peroxidase activities were diminished in samples with severe villous atrophy as compared with normal mucosa. This suggests that small intestinal mucosa with villous atrophy may produce oxidated, reactive metabolites, but further metabolism into detoxication products is decreased. This may expose persons with mucosal atrophy to possible harmful effects of environmental xenobiotics entering the body even at low doses.

Full text

PDF
1058

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alvares A. P., Kappas A. Induction of aryl hydrocarbon hydroxylase by polychlorinated biphenyls in the foeto-placental unit and neonatal livers during lactation. FEBS Lett. 1975 Feb 1;50(2):172–174. doi: 10.1016/0014-5793(75)80482-0. [DOI] [PubMed] [Google Scholar]
  2. Arnaud-Battandier F., Schmitz J., Ricour C., Rey J. Intestinal malignant lymphoma in a child with familial celiac disease. J Pediatr Gastroenterol Nutr. 1983 May;2(2):320–323. doi: 10.1097/00005176-198302020-00019. [DOI] [PubMed] [Google Scholar]
  3. Berry D. L., Slaga T. J., Wilson N. M., Zachariah P. K., Namkung M. J., Bracken W. M., Juchau M. R. Transplacental induction of mixed-function oxygenases in extra-hepatic tissues by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem Pharmacol. 1977 Aug 1;26(15):1383–1388. doi: 10.1016/0006-2952(77)90361-6. [DOI] [PubMed] [Google Scholar]
  4. Chhabra R. S. Intestinal absorption and metabolism of xenobiotics. Environ Health Perspect. 1979 Dec;33:61–69. doi: 10.1289/ehp.793361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clifton G., Kaplowitz N. The glutathione S-transferases of the small intestine in the rat. Cancer Res. 1977 Mar;37(3):788–791. [PubMed] [Google Scholar]
  6. DePierre J. W., Moron M. S., Johannesen K. A., Ernster L. A reliable, sensitive, and convenient radioactive assay for benzpyrene monooxygenase. Anal Biochem. 1975 Feb;63(2):470–484. doi: 10.1016/0003-2697(75)90371-1. [DOI] [PubMed] [Google Scholar]
  7. Dent J. G., Cagen S. Z., McCormack K. M., Rickert D. E., Gibson J. E. Liver and mammary arylhydrocarbon hydroxylase and epoxide hydratase in lactating rats fed polybrominated biphenyls. Life Sci. 1977 Jun 15;20(12):2075–2079. doi: 10.1016/0024-3205(77)90187-4. [DOI] [PubMed] [Google Scholar]
  8. Freeman H. J., Chiu B. K. Multifocal small bowel lymphoma and latent celiac sprue. Gastroenterology. 1986 Jun;90(6):1992–1997. doi: 10.1016/0016-5085(86)90272-6. [DOI] [PubMed] [Google Scholar]
  9. Freeman H. J., Chiu B. K. Small bowel malignant lymphoma complicating celiac sprue and the mesenteric lymph node cavitation syndrome. Gastroenterology. 1986 Jun;90(6):2008–2012. doi: 10.1016/0016-5085(86)90275-1. [DOI] [PubMed] [Google Scholar]
  10. Harris C. C., Vahakangas K., Newman M. J., Trivers G. E., Shamsuddin A., Sinopoli N., Mann D. L., Wright W. E. Detection of benzo[a]pyrene diol epoxide-DNA adducts in peripheral blood lymphocytes and antibodies to the adducts in serum from coke oven workers. Proc Natl Acad Sci U S A. 1985 Oct;82(19):6672–6676. doi: 10.1073/pnas.82.19.6672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hartiala K. Metabolism of hormones, drugs and other substances by the gut. Physiol Rev. 1973 Apr;53(2):496–534. doi: 10.1152/physrev.1973.53.2.496. [DOI] [PubMed] [Google Scholar]
  12. Haugen A., Becher G., Benestad C., Vahakangas K., Trivers G. E., Newman M. J., Harris C. C. Determination of polycyclic aromatic hydrocarbons in the urine, benzo(a)pyrene diol epoxide-DNA adducts in lymphocyte DNA, and antibodies to the adducts in sera from coke oven workers exposed to measured amounts of polycyclic aromatic hydrocarbons in the work atmosphere. Cancer Res. 1986 Aug;46(8):4178–4183. [PubMed] [Google Scholar]
  13. Hietanem E. Oxidation and subsequent glucuronidation of 3,4-benzopyrene in everted intestinal sacs in control and 3-methylcholanthrene-pretreated rats. Pharmacology. 1980;21(4):233–243. doi: 10.1159/000137438. [DOI] [PubMed] [Google Scholar]
  14. Hietanen E., Ahotupa M., Béréziat J. C., Park S. S., Gelboin H. V., Bartsch H. Monoclonal antibody characterization of hepatic and extrahepatic cytochrome P-450 activities in rats treated with phenobarbital or methylcholanthrene and fed various cholesterol diets. Biochem Pharmacol. 1987 Nov 15;36(22):3973–3980. doi: 10.1016/0006-2952(87)90466-7. [DOI] [PubMed] [Google Scholar]
  15. Hietanen E., Laitinen M. Dependence of intestinal biotransformation on dietary cholesterol. Biochem Pharmacol. 1978 Apr 1;27(7):1095–1097. doi: 10.1016/0006-2952(78)90163-6. [DOI] [PubMed] [Google Scholar]
  16. Hietanen E., Malaveille C., Camus A. M., Béréziat J. C., Brun G., Castegnaro M., Michelon J., Idle J. R., Bartsch H. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine. Drug Metab Dispos. 1986 Jan-Feb;14(1):118–126. [PubMed] [Google Scholar]
  17. Hoensch H. P., Steinhardt H. J., Weiss G., Haug D., Maier A., Malchow H. Effects of semisynthetic diets on xenobiotic metabolizing enzyme activity and morphology of small intestinal mucosa in humans. Gastroenterology. 1984 Jun;86(6):1519–1530. [PubMed] [Google Scholar]
  18. Hänninen O., Aitio A., Hietanen E. Physiological defence against xenobiotics at their portals of entry to the organism. Med Biol. 1979 Oct;57(5):251–255. [PubMed] [Google Scholar]
  19. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  20. McCormack K. M., Melrose P., Rickert D. E., Dent J. G., Gibson J. E., Hook J. B. Concomitant dietary exposure to polychlorinated biphenyls and polybrominated biphenyls: tissue distribution and arylhydrocarbon hydroxylase activity in lactating rats. Toxicol Appl Pharmacol. 1979 Jan;47(1):95–104. doi: 10.1016/0041-008x(79)90076-0. [DOI] [PubMed] [Google Scholar]
  21. Paglia D. E., Valentine W. N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967 Jul;70(1):158–169. [PubMed] [Google Scholar]
  22. Poland A., Glover E. Comparison of 2,3,7,8-tetrachlorodibenzo-p-dioxin, a potent inducer of aryl hydrocarbon hydroxylase, with 3-methylcholanthrene. Mol Pharmacol. 1974 Mar;10(2):349–359. [PubMed] [Google Scholar]
  23. Robinson M. F., Godfrey P. J., Thomson C. D., Rea H. M., van Rij A. M. Blood selenium and glutathione peroxidase activity in normal subjects and in surgical patients with and without cancer in New Zealand. Am J Clin Nutr. 1979 Jul;32(7):1477–1485. doi: 10.1093/ajcn/32.7.1477. [DOI] [PubMed] [Google Scholar]
  24. Salonen J. T., Alfthan G., Huttunen J. K., Puska P. Association between serum selenium and the risk of cancer. Am J Epidemiol. 1984 Sep;120(3):342–349. doi: 10.1093/oxfordjournals.aje.a113898. [DOI] [PubMed] [Google Scholar]
  25. Schmassmann H. U., Glatt H. R., Oesch F. A rapid assay for epoxide hydratase activity with benzo (a)pyrene 4,5-(K-region)-oxide as substrate. Anal Biochem. 1976 Jul;74(1):94–104. doi: 10.1016/0003-2697(76)90312-2. [DOI] [PubMed] [Google Scholar]
  26. Swinson C. M., Slavin G., Coles E. C., Booth C. C. Coeliac disease and malignancy. Lancet. 1983 Jan 15;1(8316):111–115. doi: 10.1016/s0140-6736(83)91754-3. [DOI] [PubMed] [Google Scholar]
  27. Tredger J. M., Chhabra R. S. Preservation of various microsomal drug metabolizing components in tissue preparations from the livers, lungs, and small intestines of rodents. Drug Metab Dispos. 1976 Sep-Oct;4(5):451–459. [PubMed] [Google Scholar]
  28. Uziel M., Griffin G. D., Walsh P. J. Aryl hydrocarbon hydroxylase tissue-specific activities: evidence for baseline levels in mammalian tissues. J Toxicol Environ Health. 1985;16(6):727–742. doi: 10.1080/15287398509530784. [DOI] [PubMed] [Google Scholar]
  29. Verkasalo M., Savilahti E., Rapola J., Wallgren E. I. Fibrosarcoma in a girl with celiac disease and IgA deficiency. J Pediatr Gastroenterol Nutr. 1985 Oct;4(5):839–841. doi: 10.1097/00005176-198510000-00028. [DOI] [PubMed] [Google Scholar]
  30. Ward K. P., Arthur J. R., Russell G., Aggett P. J. Blood selenium content and glutathione peroxidase activity in children with cystic fibrosis, coeliac disease, asthma, and epilepsy. Eur J Pediatr. 1984 Apr;142(1):21–24. doi: 10.1007/BF00442584. [DOI] [PubMed] [Google Scholar]
  31. Wattenberg L. W. Carcinogen-detoxifying mechanisms in the gastrointestinal tract. Gastroenterology. 1966 Nov;51(5):932–935. [PubMed] [Google Scholar]
  32. Willett W. C., Polk B. F., Morris J. S., Stampfer M. J., Pressel S., Rosner B., Taylor J. O., Schneider K., Hames C. G. Prediagnostic serum selenium and risk of cancer. Lancet. 1983 Jul 16;2(8342):130–134. doi: 10.1016/s0140-6736(83)90116-2. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES